Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Antimuscarinic use and discontinuation in an older adult population
Scott Martin Vouri
, Mario Schootman
, Seth A. Strope
, Hong Xian
,
Margaret A. Olsen
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Division of Infectious Diseases
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antimuscarinic use and discontinuation in an older adult population'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Older Adult Population
100%
Antimuscarinics
100%
Oxybutynin
18%
Immediate Release
12%
Treatment Options
6%
Multivariable
6%
Older Patients
6%
Cox Proportional Hazards Model
6%
Clinical Intervention
6%
Overactive Bladder Symptom Score (OABSS)
6%
Continued Use
6%
Treatment Discontinuation
6%
Medicare Claims Data
6%
Pharmacological Treatment
6%
New User
6%
Tolterodine
6%
Days' Supply
6%
Trospium
6%
Time to Discontinuation
6%
Grace Period
6%
Solifenacin
6%
Fesoterodine
6%
Darifenacin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Oxybutynin
100%
Overactive Bladder
33%
Tolterodine
33%
Solifenacin
33%
Fesoterodine
33%
Darifenacin
33%